| Literature DB >> 25488884 |
Fang Yuntao1, Guo Chenjia1, Zhang Panpan1, Zhao Wenjun1, Wang Suhua1, Xing Guangwei1, Shi Haifeng2, Lu Jian1, Peng Wanxin3, Feng Yun4, Jiyang Cai5, Michael Aschner6, Lu Rongzhu7.
Abstract
Autophagy is an evolutionarily conserved process in which cytoplasmic proteins and organelles are degraded and recycled for reuse. There are numerous reports on the role of autophagy in cell growth and death; however, the role of autophagy in methylmercury (MeHg)-induced neurotoxicity has yet to be identified. We studied the role of autophagy in MeHg-induced neurotoxicity in astrocytes. MeHg reduced astrocytic viability in a concentration- and time-dependent manner, and induced apoptosis. Pharmacological inhibition of autophagy with 3-methyladenine or chloroquine, as well as the silencing of the autophagy-related protein 5, increased MeHg-induced cytotoxicity and the ratio of apoptotic astrocytes. Conversely, rapamycin, an autophagy inducer, along with as N-acetyl-L-cysteine, a precursor of reduced glutathione, decreased MeHg-induced toxicity and the ratio of apoptotic astrocytes. These results indicated that MeHg-induced neurotoxicity was reduced, at least in part, through the activation of autophagy. Accordingly, modulation of autophagy may offer a new avenue for attenuating MeHg-induced neurotoxicity.Entities:
Keywords: Antioxidants; Astrocytes; Autophagy; Methylmercury; Neuroprotection; Neurotoxicity
Mesh:
Substances:
Year: 2014 PMID: 25488884 PMCID: PMC5029794 DOI: 10.1007/s00204-014-1425-1
Source DB: PubMed Journal: Arch Toxicol ISSN: 0340-5761 Impact factor: 5.153